This post was contributed by a community member. The views expressed here are the author’s own.
Vios Fertility Institute has implemented Future Fertility’s Violet™ to further enhance the patient’s experience using its non-invasive 2-D image analysis application. Using cloud-based data, Violet™ provides a comprehensive breakdown of the viability of eggs (oocytes) for women who have opted for social egg freezing, a process of cryopreservation that enables them to postpone their trying to conceive to a time of their choosing.
“I am very excited to see the use and deployment of Violet™ A.I. engine into an incredible In-Vitro Fertilization clinic such as Vios Fertility Institute,” explains Diana Olusanmi, CEO of Future Fertility. “We see this as a turning point for the company as we are now in the market with several clinics, and we are looking forward to expanding. Violet™ is a truly revolutionary technology that will change the landscape of not only social egg freezing, but In-Vitro Fertilization in general.”
Clinicians at Vios Fertility Institute are passionate about personalized, transparent treatment throughout each stage of the patient’s fertility journey. These values align with the mission of Future Fertility, a Canadian startup that has researched and engineered this innovative technology.
“Innovations like Violet™ provide new technologies which help advance the field of fertility treatment while pushing the envelope to try bold new ideas. Some are incredible pivots and others are small details…but both move the industry into higher success,” adds Dr. Angie Beltsos, CEO and Chief Medical Officer of Vios Fertility Institute.
Future Fertility was co-founded by Reproductive Endocrinologist, Dr. Dan Nayot who, with his team, developed an AI-based neural network to uncover the black box of “egg quality.” Aside from Violet™, there is currently no standardized visual classification to assess the quality or grade of eggs.
Future Fertility’s software provides added information for women who want to freeze their eggs, including:
● A tangible report for the patient that includes images of each frozen egg, offering transparency and insight into their fertility journey
● An advantage in accuracy at a rate of 20% greater than a trained embryologist. Violet™ predicts egg fertilization at about 90% accuracy and the likelihood of an embryo developing at 63% accuracy.
To learn more about Future Fertility, or find out how your clinic can benefit from this technology, please visit www.futurefertility.com. For more information on Vios Fertility Institute, please visit www.viosfertility.com
Follow Future Fertility on Facebook, Instagram, and Twitter and Vios Fertility Institute at Facebook, Instagram, and Twitter.
About Future Fertility
Future Fertility is a Canadian med-tech company that develops AI-based solutions in the area of Assisted Reproductive Technology (ART). They currently offer a non-invasive image analysis tool called Violet™, which visually assesses the probability of a human egg (oocyte) to successfully fertilize and reach a blastocyst stage embryo. For more information, contact the Future Fertility team via futurefertility.com
About Vios
Established in 2015, Vios Fertility Institute is one of the fastest growing fertility clinics in the U.S. with 11 locations in the Chicago, Milwaukee and St. Louis regions. Woman owned, the Vios mission is to help patients find their way to fertility health and treatment with the highest chances of success. Vios offers innovative, scientific, and cutting-edge treatment options along with an unparalleled patient experience. www.ViosFertility.com
The views expressed in this post are the author’s own. Want to post on Patch?
Credit: Source link
